Providers should monitor weight trajectory , GI tolerability (nausea, vomiting, constipation) , signs of pancreatitis (persistent severe abdominal pain vomiting), gallbladder disease (RUQ pain, fever, jaundice), hydration/renal function when clinically indicated (risk of AKI with severe GI effects), blood pressure , and glucose metrics (especially if combined with insulin or sulfonylureas due to hypoglycemia risk)
Patients experiencing unintentional weight loss beyond expected therapeutic effects , fever, or night sweats alongside digestive symptoms should seek medical assessment, as these may suggest conditions unrelated to semaglutide
At baseline, these remarkably effective medications are tough to get unless you have type 2 diabetes
11-12 What are common side effects of Ozempic
The GLP-1 craze may be coming for Fido and Fluffy next
Your prescription is processed, and medication is discreetly shipped directly to your door